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Over a 9-yt'ar period, 58 patients who had pre"ious 
portasyslemic shunt procedures unden-ent orthoto-
pic liver transplantation (OtTx) under a cyclo-
sporine-steroid immunosuppresshe regimen. The 
types of shunt used were distal splenorenal (18 pa-
tients), mesocaval (17 patients). end-to-side porta-
caval (II patients). side-to-side portaca,'al (5 pa-
tients) and proximal splenorenal (7 patients). The 
mean interval between shunt and transplantation 
was 6 years. There was no statistical difference in 
survival between patients with pre"ioU5 shunts and 
the entire population of patients with primary liver 
transplantation performed during the same period 
of time. Age, sex, shunt patency, status of portal 
vein. and use of vein or artery graft did not affect 
survival. Child's classification had a significant in-
nuence on graft survival. even though no difference 
was subsequently observed in patient sun-ivaI. A 
progressively improved intraoperath'e strategy and 
the use of "eno-venous bypass and Unh-ersity of 
Wisconsin presen-ation solution had a significant 
impact on blood loss, length of operation, length of 
stay in intensive care unit, and ultimately. on sur-
vival. Distal splenorenal and mesornal shunts with 
no or minimal hilum disieclion art' safer shunts if 
subsequent transplantation is planned:, in fact, their 
9-year survival was 879{-. wbereas all other shunts 
were associated with a survival no belter than 529c 
(p <0.006). 
O perath'e portasystemic decompression has been doc-
umented to control variceal bleeding in cirrhotic 
patients [/-1). Numerous prospective randomized trials 
have been reported that compare the various surgical 
procedures. Among the many options, the selective or 
distal splenorenal shunt has the advantage of resulting in 
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a lower incidence of postshunt encephalopathy [4-7]. 
Sclerotherapy is another very successful option for the 
short-term management of variceal bleeding. but the 
overall rebleeding rate is higher in patients undergoing 
this procedure when compared with patients undergoing 
operative portasystemic decompression [8-11]. Neither 
shunting procedures nor sclerotherapy have had an im-
pact on patient survival [/-1,5,9,/0,/2]. However, both 
can be highly effective temporizing measures. 
Orthotopic liver transplantation (OLTx) is the only 
potentially curative treatment for end-stage liver disease 
[/3] and is the ideal, treatment to relieve portal hyperten-
sion caused by sinusoidal (intrahepatic) block. Patients 
with previous portasystemic shunt procedures have a re-
sulting set of complicating technical and anatomic factors 
that make the performance of liver transplantation even 
more challenging; hemodynamic disturbances.. portal 
vein abnormalities. and arterialized adhesions are exam-
ples of these complications. Nonetheless, succcssfulliver 
transplantation in patients with previous portasystemic 
shunt bas already been reported by us [14] and others 
[/5]. I 
In this paper, we present our experience over a 9-year 
period of cyclosporine immunosuppression in 58 consecu-
tive patients with end-stage liver disease and some type of 
operative portasystemic shunt who subsequently under-
went OLTx. The results demonstrate that the survival in 
this unique candidate group is similar to those obtained in 
our overall liver transplantation population. 
PATIENTS AND METHODS 
Between March 1980 and March 1989. a total of 
1,445 primary OLTx procedures were performed at the 
University of Colorado in Denver, and beginning in Janu-
ary 1981, at the University of Pittsburgh. Futy-eight of 
these patients had undergone previous operative portasys-
temic decompression for variceal bleeding. They have 
now been followed from 6 months to 10 years after trans-
plantation. 
~re were 26 male and 32 fema.le patients., with a 
mean age of 39.2 ± 13 years (range: 4 to 64 yc:an).Sixof 
the patients were less than 18 years old at the time of 
OLTL Twenty-three patients were classified as Child's 
class Band 35 as Child's C at the time of the pre-OL Tx 
workup. All patients were given immunosuppression with 
cyclosporine and prednisone [/6] to which azathioprine 
and antilymphoid globulins were added when clinically 
required. 
The following parameters were reviewed for this 
study: type of previous shunt. time interval from the cre-
ation of the portasystemic shunt to OL Tx. shunt patency 
at the time of OL Tx. size and characteristics 01 the portal 
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AgIn 1. 0Ift... time periods In the uglcal treatment 01 
pedents wtI'I previous por1aSySt8mIc stults. The I'IIII1ber of pa-
tferIs wt-c InB went transplantation per yeerls given. For 1987, 
• rdcatas the period from January to October when CoIIn's 
~ soUion was used; b indicates the period from HI> 
WI'\"'t)er to [)ec:etri)er when 1he U,lverslty of WIsconsrI (tNi) 
~ soUSon was used. AsterIsk indicates the patients 
who UI dei went transplantation In .. first 3 months Of 1989; ... 
p ecIc*Bd runber lor the yeet Is shown. 
YCin., management of the actual shunt during the trans-
plantatioo procedure. use of vein or artery homograft 
du.rina surgery, duration of anesthesia, intraoperative 
blood loss., duration of ischemia of the graft, length of 
time in intensive care unit, and graft and patient survival 
aftc::r OL Tx. 
Because of the refinements in surgical technique and 
orp.n preservation that occurred over the years, the rc-
sul:s were partitioned in three consecutive groups. At 
lirA. the use of veno-venous bypass was used to divide the 
pltlents into Group I (no bypass) and Group 2 (bypass 
used). In Group 3, the University of Wisconsin solution 
1IV'U used for graft preservation, replacing the Collins 
solution previously used for Groups I and 2 (Figure 1). 
'The results, unless indicated, are expressed as mean ± 
sta.Ddard deviation of the mean and analyzed using Fish-
cr"s exact test. Estimated survivals were calculated and 
axnparcd usina the generalized Savage (Mantel-Cox) 
and Wilcoxon (Brenslow) life-table analysis, run on the 
BMDF-2L statistical software package (University of 
Ulifornia). 
TABLED 
TABLE I 
PrImary Dlagnosll of 58 LIver Recipients wtItI Previous 
POf1alyltemlc Shunt 
Postneaollc clrrhosla 
PrImaIy biliary clrrtooslt 
A1pha-1-enthrypsln deficiency 
WIlson', cIIsMM 
Budd-ChIIrI syndrome 
CongenIIaI hepatic fibrosis 
ScleroU1g c:tlolangltls 
Alcoholic cIrrtloeIs 
A~ ctv'onIc hepatltil 
HemophIle Eml~ hemosiderOlil) 
Neonatal hepetltll 
Secondary biliary clrrhosIs 
RESULTS 
15 
11 
e 
5 
5 
4 
3 
3 
3 
The liver disease, type of previous shunt, and mean 
interval between the shunt procedure and OL Tx are sum-
marized in Tables I and II. Postnecrotic and primary 
biliary cirrhosis accounted for 45% of the cases. The types 
of shunts used were distal splenorenai (18 patients), me-
socaval (17 patients), end-to-side portacaval (II pa-
tients), proxima1 splenorenal (7 patients), and side-to-
side portacaval (S patients), The mean interval between 
the shunt and OLTx was approximately 6 years. This 
averaged 3.5 years in patients with side-t<>-side portacaval 
shunts and 7,9 years in patients with proximal splenor-
enal shunts. These differences were not statistically sig-
nificanL 
There was DO statistically significant difference in the 
actuarial 9-year survival between patients who under-
went previous portasystemic shunt before transplantation 
and those who did not. In Figure 2, survival of portasyste-
mic shunt patients is plotted against the survival of the 
entire population of 1.445 patients who received primary 
OLTx during the same period of time. Sixty-seven per-
cent of the patients with portasystemic shunts were alive 
5 years after OL Tx compared with 65% of those without 
previous shunts. 
Patient age and sex did not influence the outcome. 
Shunt patency at the time of OL Tx, an atrophic or scle-
rotic portal vein. or the use of vein or arterial graft did not 
have a statistical impact on either graft or patient surviv-
al. The pretransplantation Child's status of the candidate 
had a definite influence on intraoperative blood loss, du-
Characterlltlca 01 the Studr Population 
Type of IntetvaI i'I v .... from 
Pr..mua No. of ,. ShLnt to a. Tx 
9'UII PatIents (rnedien & I'WI(III) (mean % SO) 
Por1aI venow-maInIalnlng 
0ls1aI apIenor .... ,. 41 (12-81, 5.11 % 0.' 
mor1af~ 
~ 17 39 (7-51) 5.1 % 0.' 
~ 11 42 (4-51, 7.7%2.5 
~ aIde-to-sIde 5 32(20-14) 3.5 % 0.7 
Proximll IpleIlOl." 7 21 (21 .... ,' 7 .• :t 1.1 
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ration of the operation, length of ICU stay (Table III), 
and ultimately, on graft survival. The graft surviv~1 was 
significantly different between Child's B and Child's C 
patients (Figure 3). However, bccauseoftbe timely resort 
to retransplantation in cases of graft failure, no signifi-
cant difference was observed in patient survival (Figure 
3), which was 74% for the Child's B and 67% for the 
Child's C grou~K 
The fll'St 10 patients in the series (seen from 1980 to 
1983) did not have the advantage of the intraoperative 
vena-venous bypass system [J7].1n a second group of 24 
patients (seen from 1983 to October 1987), the native 
hepatectomy was performed under bypass conditions 
(Figure 4 and Table III). In those patients, at least one 
cavacaval bypass was always used, and the portal limb of 
the system was added whenever allowed by the intraoper-
ative conditions of the portal veill and the previous shunt. 
In a third group of 24 patients (seen from October 1987 
to March 1989), the bypass was also employed, and the 
University of Wisconsin solution was used for graft pres-
ervation [18], replacing the Collins solution previously 
employed in drou~ I and 2. 
The use of vena-venous bypass was probably responsi-
ble for reducing the intraoperative blood loss from 60 
units in Group I to 39 units ill Group 2 and may have 
contributed to a shorter operation time (from 15 bours to 
12 hours, respectively). There was a reduction of the 
average intensive care unit stay from 96 days for the 
patients without bypass to 16 days when vena-venous 
bypass was used. 
With the introductioR of the Wisconsin preservation 
solution, there was a signiftcantly longer duration of cold 
ischemia of the graft. but the postreperfusion liver func-
tion was improved [18]. In Group 3 patients (bypass and 
Wisconsin solution), the duration of ischemia of the graft 
increased to 13 hours from a previous average time of 7 
hours when the solution was not used (Groups I and 2). 
The longer and more effective preservation allowed a 
further planning of the operation, with better control of 
the bleeding and elimination of haste in reperfusing the 
organ. These facts are reflected in a further decrease in 
blood loss (to 19 units) and intensive care unit stay (to 8 
days) in patients who received the solution (Table III). 
The actuarial survival also improved significantly (Figure 
4). 
The type ."If previous shunt had an impact on survival 
(Figure S). Previous shunt procedures with no liver hilum 
TABLE III 
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FIgure 2. &IvIvaI of patients with portasystemIc shc.nt (PSS) (58 
patients) versus !he entire population wllhout PSS (1.4-45 pa-
tients) who IIlderwent transpWrtation IniBr cyclosporlne IrrvT"u-
llOSt.WI"essIon from March 1980 to Mlwch 1989. No statistical 
difference Is noted. 
dissection were safer. Patients with mesocaval and distal 
splenorenal shunts had a 5- and 9-ycar survival of 95% 
and 87%, respectively, whereas no previous shunt was 
associated with a survival better than 52% at the same 
time intervals. Those differences were highly significant 
(p <0.01 by Breslow, <0.006 by Mantel-Cox). 
Thirty-one of the 58 patients had defmite portal vein 
abnormalities determined by angiograpby or at the time 
of surgery. A thrombosed, small-caliber, or partially oc-
cluded portal vein did not preclude transplantation and 
did not influence survival. The portal limb of the vena-
venous bypass was omitted in most of these situations, 
while a partial (femoral-axillary) bypass was always em-
ployed in Groups 2 and 3, Complete bypass was used in 
most cases in which there was a thrombosed or nonfunc-
tional previous portasystemic shunt. 
Abnormalities of the portal vein just distal to the 
confluence of the superior mesenteric and splenic veins 
required the use of a short segment of iliac vein graft for 
anastomosis to the donor portal vein. Ten patients with 
portal vein graft bad no difference in survival compared 
with the rest of the present series. The technique of plac-
ing a vein homograft on a clotted or atrophic portal vein 
has been previously described [/9]. More recently. an 
additional method of a vein jump-graft from the sunerior 
mesenteric vein has been developed (20). 
Blood Loa and Durallon Of Surgery, ischemia, .nd ICU atlr In DIr ... ..,. Group. Of ,., ...... 
Blood lola (U) 
OR time (In) 
IIdIernIa em) 
ICU .r.y (dIIyt) 
G-oup1 
(n - 10) 
8O:i:34 
15 :i: 4 
7:i:2 
9t:i: 113 
Group 2 
en - 24) 
3t:i:33 
12:i: 4 
7:i:2 
,.:i: 25 
G-oup3 
(n • 24) 
OIIId's Clast B OIIId"s CIuI C 
en - 23) en - 35) 
---------------------------------19:i: 25 
12:i: 4 
13:i: 4 
a:i: 11 
3O:i:34 
13:i: 3 
.:i:4 
11 :i: 21 
37:i: 32 
14:i: 5 
11:i: 5 
43:i: 170 
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Flgwe 5. Inftuence of clfferent types of previous stU"d on st.I'VivaI 
after transplantation. BoIh mesocaval and cIstaI splenorenaJ 
stu'It procecbes had • sigliflcant positive ~ on st.I'VivaI 
when COf11*ed with OCher stults (p <0.01 Breslow; <0.006 
Mantel Cox~ DSAS = distal splenorenal; MCS = mesocaval; 
PCE-S = portacaval ~to-side: PCS-S = portacaval sid&-to-
side; PSRS = proximal splenorenal. 
Some shunt-specific technical modifications of the 
transplantation procedure were commonly applied. Arte-
rialization of the graft was carried out first whenever 
restoration of portal flow was difficult for any reason. 
Dis.al splenorenal shunl: A double venous bypass 
was used in 9 of our 18 patients. Of the nine patients in 
whom bypass was not employed, three underwent trans-
plantation prior to the bypass era, and in the other six, 
only partial femoral bypass was used because of either a 
thin-walled portal vein (one patient), thrombosed previ-
ous shunt (one patient), or thrombosed portal vein (four 
patients). A vein graft was necessary to reconstruct the 
thrombosed portal vein, and the arterial anastomosis was 
performed fllSt in 10 of 18 patients because of a concern 
for adequate portal flow after unclamp. The closure of a 
previous patent splenorenal shunt is rcc:ommeoded at the 
end of the transplantation procedure after reperfusion of 
80 
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FIgIn 4. Differences In swvIvaJ between cIfferent 1100JpS of 
patients (p <0.01 by Breslow, <0.008 by ~FK 
the new graft and can be performed simply with a sple-
nectomy. Removal of the spleen avoids any dangerous 
dissection around the splenic vein or the old splenorenal 
anastomosis. 
Mesocaval shunt: A patent shunt obviated the need 
for the portal limb of the bypass, but the shunt was often 
isolated and encircled at the onset of the operation in 
order to be prepared for immediate ligation after portal 
revascularization. When prosthetic materials had been 
used for the previous mesocaval anastomosis, a double 
firing of a T A35 intestinal stapler was usually sufficient 
to obstruct the old shunt. Complete bypass was per-
formed in six of our patients when the shunt was throm-
bosed. 
Portacaval shunt (end-Io-side. sick-to-side): The 
previous surgery on the liver hilum renders the dissection 
for OL Tx quite difficult in these patients compared with 
the previous two kinds of shunt. Thirteen of the 16 pa-
tients underwent transplantation prior to the bypass era. 
We recommend partial (femoro-axillary) bypass, leaving 
the shunt open as long as possible, since it 5en"es the same 
purpose as the portal bypass. The lower caval anastomo-
sis was usually performed while leaving the shunt undis-
turbed. Difficulties in dissection and the desire to preserve 
the shunt as long as possible frequently resulted in pri-
mary arterial revascularization (13 or 16 patients). 
Proximal splenorenal shunt: As with the meso-caval 
shunt, a patent shunt obviated the need for portal bypass. 
A partial bypass was performed in five of the patients, 
and the shunt was ligated immediately after portal vein 
unclamping. In two of those casc:s, with a concomitant 
thrombosed portal vein, the arterial anastomosis was per-
formed prior to the portal vein anastomosis. In one case 
with a thrombosed sbunt, total bypass was performed 
even though the portal vein wall was abnormally thin. 
COl\lMENTS 
Our cumulative experience suggests that while either 
previous shunts, portal vein abnormalities. or the need for 
portal vein reconstruction significantly increase the com-
plexity of the procedure as determined by the operative 
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time and blood loss, these conditions do not prohibit suc-
cessful hepatic transplantation. 
A number of factors can contribute to good results. 
Careful patient evaluation and selection may be impor-
tant. "There was a very low incidence of alcoholic cirrhosis 
(three patients), while metabolic liver disease, primary 
biliary cirrhosis, and congenital hepatic fibrosis formed a 
higber relative proportion of the patients who underwent 
portasystemic shunt. Survival after portasystemic shunt 
is much lower in patients with alcoholic cirrhosis (45% 
lO-year survival) than in those patients in whom portal 
hypertension results from some other form of underlying 
liver disease (67% lO-year survival) [21-23]. The small 
number of alcoholic patients in our series may have been 
a favorable condition. The importance of patient selection 
was shown by the fact that preoperative transplantion 
status expressed by Child's class was a significant deter-
minant of graft survival (Figure 3). 
Careful preoperative evaluation of the portal vein and 
shunt anatomy in liver transplantation candidates can be 
carried out using arteriography, magnetic resonance im-
aging, and Doppler ultrasonography to evaluate porta) 
flow and shunt patency. These studies help in the develop-
ment of an appropriate surgical strategy at the time of 
transplantation of the liver. Surgical technique is certain-
ly a dominant factor in the treatment of such patients, 
who were operated on by our most experienced surgeons. 
There was no significant impact 00 prognosis exerted per 
se by intraoperative difficulties such as thrombosis of the 
portal vein or use rX vein graft. 
Distal sp)enorenal and mesocaval shunts presented a 
better situation for OLTx than any other portasystemic 
shunt in terms of both technical ease and graft or patient 
survival. There was easier access to the hepatic hilum of 
patients with those types of shunts at the time of trans-
plantation. and iftbe porta) vein was patent, there was no 
contraindication to the use of veno-venous bypass. Post-
operative portal vein thrombosis occurred in three pa-
tients in the entire series of portasystemic shunt patients. 
It was previously reported that prior operations on the 
splanchnic circulation predisposed to peri-transplanta-
tion portal vein complications [24). 
The role for OLT" in the treatment of portal hyper-
tension should no longer be considered controversial. Liv-
er transplantation was able to achieve 79% I-year and 
71% S-year survival in patients who had end-stage liver 
disease in addition to a history of bleed'.ng esop~lageal 
varices or who were actively bleeding at the time of trans-
plantation [25]. These results were obtained regardless of 
the cause of cirrhosis (including a1coholism) and were 
better than those obtained with shunt operations {J .4-
7,12,21-231, especially in patients with advanced hepatic 
failure (Child's class C). However. shunt operations still 
have a role in the treatment of portal hypertension and 
should be considered complementary to transplantation 
in selected cases. The Warren shunt is the best of these 
procedures. 
More and more reliance has been placed on scleroth-
erapy, with which survival similar to that of selective 
shunts can be achieved but with an higher incidence of 
LlHR qoA:-;pmiA~qKyqfl~ AFTER PORTASYSTBUC SHUNT 
rebleeding [8-11,26] and a significant incidence of 
esophageal perforation or strictures [17,28]. Nonethe-
less, sclerotherapy has been established in the control of 
acute variceal hemorrhage and in guaranteeing better 
candidates for liver transplantation [27]. Thus. a distal 
splenorenal anastomosis may be the preferred way to 
relieve portal hypertension only in patients who have 
Child's A status. 
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